Tech Company Financing Transactions
Adarza BioSystems Funding Round
On 2/6/2020, Adarza BioSystems raised $25 million in Series D funding from 3x5 Partners, Lightchain and private investors.
Transaction Overview
Company Name
Announced On
2/6/2020
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series D
Investors
3x5 Partners (Lead Investor) (Joseph Biller)
Lightchain (Lead Investor) (Drew Dennison)
Proceeds Purpose
Adarza plans to use the funds to support full commercialization of ZIVA, its automated biological testing platform for academic and clinical research.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2184 Welsch Industrial Ct.
St. Louis, MO 63146
USA
St. Louis, MO 63146
USA
Phone
Website
Email Address
Overview
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bryan Witherbee
VP - Bus. Development
Linda Meeh
VP - Engineering
Jason Mitchell
VP - Engineering
Randy Motluck
VP - Engineering
Christopher Striemer
VP - Finance
Nakul Tandon
VP - Manufacturing
Bob Crepin
VP - R & D
Jon Schmuke
VP - Regulatory Affairs
Nannette Langevin
Browse more venture capital transactions:
Prev: 2/6/2020: Deliverr venture capital transaction
Next: 2/6/2020: Outset Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs